VSS Endo1 set to continue growth trajectory in 2021 with $ 115 million in new funding
Leading Endodontics Partnership Organization (EPO) Performs Most Successful Exercise Yet
New debt financing further positions platform investment to meet growing demand for endodontic procedures as economy rebounds from COVID-19
VSS Capital Partners (“VSS”), a private equity firm investing in the business services, health, education and information sectors, is pleased to announce that its investment in the platform Endo1 Partners (“Endo1” or “the Company”) has secured $ 115 million in debt financing to support its growth trajectory and continued expansion as a fast growing Endodontic Partnership Organization (EPO).
Endo1, headquartered in Houston, Texas, provides non-clinical administrative support to affiliated and independent endodontic practices in 10 states in the United States. Endo1’s strong back office infrastructure capabilities provide accounting, invoicing, business development, human resources, IT, marketing and recruiting services allowing independent endodontic practices to focus on providing patient care.
“Endo1’s growth trajectory reflects VSS’s proven expertise in transforming traditional high-demand businesses in alignment with talented management teams and flexible capital,” said Jeffrey Stevenson, Managing Partner of VSS. “VSS’s structured capital investments allow our platform companies to accelerate their growth, access new resources and expand their activities into attractive markets.
VSS, a seasoned investor focused on buying and building the lower middle market with more than a decade of experience in developing fast growing businesses, invested in Endo1 in November 2019, working closely with the ‘business leadership team to establish a highly scalable and rapid platform. growing network of independent endodontic specialists. To date, Endo1 has added 35 new practices to its network, with additional partnerships already underway.
VSS has a long tradition of partnering with lower mid-size companies, providing strategic advice on growth initiatives and working closely with management as a minority or majority investor.
Endo1’s continued progression as a VSS holding company reflects the added value the company adds after investment. It also comes at a time when many small U.S. businesses (“LMMs”) are poised to realize the benefits of the $ 1.9 trillion economic stimulus and the easing of restrictions on businesses during the pandemic.
“We are delighted to have found in VSS a strategic partner who truly understands the needs, challenges and potential of small businesses on the verge of growth but limited by access to capital,” said Dr Daryl Dudum and the Dr Matthew Haddad, Co-Founders and Co-CEOs of Endo1 Partners. “We are committed to providing our current and potential endodontist partners with the best administrative support services so that they can focus on providing care that improves the lives of patients while being able to manage their practices more effectively. “
“VSS is excited about the opportunity to support Endo1’s plans to add 50 new locations to its network in 2021, which reflects the foundation we have established for the continued growth of the company,” said Yash Kandoi, Director of VSS who leads VSS’s investment in Endo1. “We believe Endo1 is well positioned to meet what we expect to be increased demand for endodontic procedures in the post-pandemic economy.”
The transaction team on Endo1 included Victoria Durand, a partner at VSS who focuses on the company’s investments in healthcare.
VSS has a long history of partnering with talented leadership teams and founders of healthcare service companies to identify strategic acquisitions and drive operational improvements that create lasting value, including in medical practice management and healthcare. behavioral.
VSS Capital Partners (“VSS”), a private equity firm, invests in the business services, health, education and information sectors. Based in New York City, VSS provides capital for growth financing, recapitalizations, strategic acquisitions and buyouts to lower middle market companies and executive teams with the goal of building businesses organically as well as through the through targeted complementary acquisition programs. VSS makes privately traded investments throughout the capital structure and invests in situations requiring control or non-control stocks, mezzanine securities and structured equity securities. VSS has more than three decades of experience, has invested in 88 portfolio companies, with more than 350 complementary acquisitions, and manages $ 3.5 billion of total committed capital in 7 funds. For more information, please visit: www.vss.com.
Endo1 is a leading provider of emergency and essential dental services focused on high quality endodontic treatments with a multi-site, multi-service and scalable platform positioned for growth. Present nationwide, Endo1 Partners provides comprehensive business and operational support services to its endodontic practices. The company partners with top endodontists across the country with the goal of dramatically reducing their administrative burden, so they can spend more time at the heart of their practice, providing high quality dental care to patients. For more information, please visit: www.endo1partners.com.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20210407005295/en/
PRESS CONTACT FOR VSS: